Global Neurology Clinical Trial Market Research Report 2025(Status and Outlook)
The market for neurology clinical trials encompasses the complex ecosystem of research and development activities focused on evaluating the safety and efficacy of novel therapeutic interventions for neurological disorders, including but not limited to Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and amyotrophic lateral sclerosis (ALS), involving a wide range of stakeholders such as pharmaceutical and biotechnology companies, contract research organizations (CROs), academic medical centers, regulatory agencies, and patient advocacy groups, all operating within a highly regulated environment that demands rigorous study designs, specialized endpoints, and patient recruitment strategies tailored to the unique challenges of neurological conditions, which often involve progressive, heterogeneous diseases with variable symptom presentation and a critical need for biomarkers to objectively measure treatment effects.
The global Neurology Clinical Trial market size was estimated at USD 520.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurology Clinical Trial market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurology Clinical Trial market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurology Clinical Trial market.
Global Neurology Clinical Trial Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BrainStorm Cell Therapeutics
Opexa Therapeutics
Caladrius Biosciences
U.S. Stem Cell
Lonza
Bristol Myers Squibb
Corning Incorporated
Vericel Corporation
Catalent
Lineage Cell Therapeutics
Castle Creek Biosciences
Sangamo Therapeutics
Novartis
Holostem Terapie Avanzate S.R.L
Pharmicell
Tego Science
Autolus therapeutics
Bayer AG
Sartorius AG
Daiichi Sankyo
Takeda Pharmaceutical Company
Sumitomo Chemical Co
Market Segmentation (by Type)
Bone Marrow
Epidermis
Mesenchymal Stem Cells
Haematopoietic Stem Cells
Chondrocytes
Market Segmentation (by Application)
Neurodegenerative Disorders
Cardiovascular Disorders
Orthopedics
Wound Healing
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurology Clinical Trial Market
Overview of the regional outlook of the Neurology Clinical Trial Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurology Clinical Trial Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurology Clinical Trial, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neurology Clinical Trial market size was estimated at USD 520.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurology Clinical Trial market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurology Clinical Trial market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurology Clinical Trial market.
Global Neurology Clinical Trial Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BrainStorm Cell Therapeutics
Opexa Therapeutics
Caladrius Biosciences
U.S. Stem Cell
Lonza
Bristol Myers Squibb
Corning Incorporated
Vericel Corporation
Catalent
Lineage Cell Therapeutics
Castle Creek Biosciences
Sangamo Therapeutics
Novartis
Holostem Terapie Avanzate S.R.L
Pharmicell
Tego Science
Autolus therapeutics
Bayer AG
Sartorius AG
Daiichi Sankyo
Takeda Pharmaceutical Company
Sumitomo Chemical Co
Market Segmentation (by Type)
Bone Marrow
Epidermis
Mesenchymal Stem Cells
Haematopoietic Stem Cells
Chondrocytes
Market Segmentation (by Application)
Neurodegenerative Disorders
Cardiovascular Disorders
Orthopedics
Wound Healing
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurology Clinical Trial Market
Overview of the regional outlook of the Neurology Clinical Trial Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurology Clinical Trial Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurology Clinical Trial, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurology Clinical Trial
1.2 Key Market Segments
1.2.1 Neurology Clinical Trial Segment by Type
1.2.2 Neurology Clinical Trial Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGY CLINICAL TRIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurology Clinical Trial Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neurology Clinical Trial Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGY CLINICAL TRIAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurology Clinical Trial Product Life Cycle
3.3 Global Neurology Clinical Trial Sales by Manufacturers (2020-2025)
3.4 Global Neurology Clinical Trial Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurology Clinical Trial Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurology Clinical Trial Market Competitive Situation and Trends
3.8.1 Neurology Clinical Trial Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurology Clinical Trial Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGY CLINICAL TRIAL INDUSTRY CHAIN ANALYSIS
4.1 Neurology Clinical Trial Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGY CLINICAL TRIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurology Clinical Trial Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurology Clinical Trial Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGY CLINICAL TRIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurology Clinical Trial Sales Market Share by Type (2020-2025)
6.3 Global Neurology Clinical Trial Market Size Market Share by Type (2020-2025)
6.4 Global Neurology Clinical Trial Price by Type (2020-2025)
7 NEUROLOGY CLINICAL TRIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurology Clinical Trial Market Sales by Application (2020-2025)
7.3 Global Neurology Clinical Trial Market Size (M USD) by Application (2020-2025)
7.4 Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
8 NEUROLOGY CLINICAL TRIAL MARKET SALES BY REGION
8.1 Global Neurology Clinical Trial Sales by Region
8.1.1 Global Neurology Clinical Trial Sales by Region
8.1.2 Global Neurology Clinical Trial Sales Market Share by Region
8.2 Global Neurology Clinical Trial Market Size by Region
8.2.1 Global Neurology Clinical Trial Market Size by Region
8.2.2 Global Neurology Clinical Trial Market Size Market Share by Region
8.3 North America
8.3.1 North America Neurology Clinical Trial Sales by Country
8.3.2 North America Neurology Clinical Trial Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurology Clinical Trial Sales by Country
8.4.2 Europe Neurology Clinical Trial Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurology Clinical Trial Sales by Region
8.5.2 Asia Pacific Neurology Clinical Trial Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurology Clinical Trial Sales by Country
8.6.2 South America Neurology Clinical Trial Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurology Clinical Trial Sales by Region
8.7.2 Middle East and Africa Neurology Clinical Trial Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGY CLINICAL TRIAL MARKET PRODUCTION BY REGION
9.1 Global Production of Neurology Clinical Trial by Region(2020-2025)
9.2 Global Neurology Clinical Trial Revenue Market Share by Region (2020-2025)
9.3 Global Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurology Clinical Trial Production
9.4.1 North America Neurology Clinical Trial Production Growth Rate (2020-2025)
9.4.2 North America Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurology Clinical Trial Production
9.5.1 Europe Neurology Clinical Trial Production Growth Rate (2020-2025)
9.5.2 Europe Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurology Clinical Trial Production (2020-2025)
9.6.1 Japan Neurology Clinical Trial Production Growth Rate (2020-2025)
9.6.2 Japan Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurology Clinical Trial Production (2020-2025)
9.7.1 China Neurology Clinical Trial Production Growth Rate (2020-2025)
9.7.2 China Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BrainStorm Cell Therapeutics
10.1.1 BrainStorm Cell Therapeutics Basic Information
10.1.2 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Overview
10.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Market Performance
10.1.4 BrainStorm Cell Therapeutics Business Overview
10.1.5 BrainStorm Cell Therapeutics SWOT Analysis
10.1.6 BrainStorm Cell Therapeutics Recent Developments
10.2 Opexa Therapeutics
10.2.1 Opexa Therapeutics Basic Information
10.2.2 Opexa Therapeutics Neurology Clinical Trial Product Overview
10.2.3 Opexa Therapeutics Neurology Clinical Trial Product Market Performance
10.2.4 Opexa Therapeutics Business Overview
10.2.5 Opexa Therapeutics SWOT Analysis
10.2.6 Opexa Therapeutics Recent Developments
10.3 Caladrius Biosciences
10.3.1 Caladrius Biosciences Basic Information
10.3.2 Caladrius Biosciences Neurology Clinical Trial Product Overview
10.3.3 Caladrius Biosciences Neurology Clinical Trial Product Market Performance
10.3.4 Caladrius Biosciences Business Overview
10.3.5 Caladrius Biosciences SWOT Analysis
10.3.6 Caladrius Biosciences Recent Developments
10.4 U.S. Stem Cell
10.4.1 U.S. Stem Cell Basic Information
10.4.2 U.S. Stem Cell Neurology Clinical Trial Product Overview
10.4.3 U.S. Stem Cell Neurology Clinical Trial Product Market Performance
10.4.4 U.S. Stem Cell Business Overview
10.4.5 U.S. Stem Cell Recent Developments
10.5 Lonza
10.5.1 Lonza Basic Information
10.5.2 Lonza Neurology Clinical Trial Product Overview
10.5.3 Lonza Neurology Clinical Trial Product Market Performance
10.5.4 Lonza Business Overview
10.5.5 Lonza Recent Developments
10.6 Bristol Myers Squibb
10.6.1 Bristol Myers Squibb Basic Information
10.6.2 Bristol Myers Squibb Neurology Clinical Trial Product Overview
10.6.3 Bristol Myers Squibb Neurology Clinical Trial Product Market Performance
10.6.4 Bristol Myers Squibb Business Overview
10.6.5 Bristol Myers Squibb Recent Developments
10.7 Corning Incorporated
10.7.1 Corning Incorporated Basic Information
10.7.2 Corning Incorporated Neurology Clinical Trial Product Overview
10.7.3 Corning Incorporated Neurology Clinical Trial Product Market Performance
10.7.4 Corning Incorporated Business Overview
10.7.5 Corning Incorporated Recent Developments
10.8 Vericel Corporation
10.8.1 Vericel Corporation Basic Information
10.8.2 Vericel Corporation Neurology Clinical Trial Product Overview
10.8.3 Vericel Corporation Neurology Clinical Trial Product Market Performance
10.8.4 Vericel Corporation Business Overview
10.8.5 Vericel Corporation Recent Developments
10.9 Catalent
10.9.1 Catalent Basic Information
10.9.2 Catalent Neurology Clinical Trial Product Overview
10.9.3 Catalent Neurology Clinical Trial Product Market Performance
10.9.4 Catalent Business Overview
10.9.5 Catalent Recent Developments
10.10 Lineage Cell Therapeutics
10.10.1 Lineage Cell Therapeutics Basic Information
10.10.2 Lineage Cell Therapeutics Neurology Clinical Trial Product Overview
10.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Product Market Performance
10.10.4 Lineage Cell Therapeutics Business Overview
10.10.5 Lineage Cell Therapeutics Recent Developments
10.11 Castle Creek Biosciences
10.11.1 Castle Creek Biosciences Basic Information
10.11.2 Castle Creek Biosciences Neurology Clinical Trial Product Overview
10.11.3 Castle Creek Biosciences Neurology Clinical Trial Product Market Performance
10.11.4 Castle Creek Biosciences Business Overview
10.11.5 Castle Creek Biosciences Recent Developments
10.12 Sangamo Therapeutics
10.12.1 Sangamo Therapeutics Basic Information
10.12.2 Sangamo Therapeutics Neurology Clinical Trial Product Overview
10.12.3 Sangamo Therapeutics Neurology Clinical Trial Product Market Performance
10.12.4 Sangamo Therapeutics Business Overview
10.12.5 Sangamo Therapeutics Recent Developments
10.13 Novartis
10.13.1 Novartis Basic Information
10.13.2 Novartis Neurology Clinical Trial Product Overview
10.13.3 Novartis Neurology Clinical Trial Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Holostem Terapie Avanzate S.R.L
10.14.1 Holostem Terapie Avanzate S.R.L Basic Information
10.14.2 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Overview
10.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Market Performance
10.14.4 Holostem Terapie Avanzate S.R.L Business Overview
10.14.5 Holostem Terapie Avanzate S.R.L Recent Developments
10.15 Pharmicell
10.15.1 Pharmicell Basic Information
10.15.2 Pharmicell Neurology Clinical Trial Product Overview
10.15.3 Pharmicell Neurology Clinical Trial Product Market Performance
10.15.4 Pharmicell Business Overview
10.15.5 Pharmicell Recent Developments
10.16 Tego Science
10.16.1 Tego Science Basic Information
10.16.2 Tego Science Neurology Clinical Trial Product Overview
10.16.3 Tego Science Neurology Clinical Trial Product Market Performance
10.16.4 Tego Science Business Overview
10.16.5 Tego Science Recent Developments
10.17 Autolus therapeutics
10.17.1 Autolus therapeutics Basic Information
10.17.2 Autolus therapeutics Neurology Clinical Trial Product Overview
10.17.3 Autolus therapeutics Neurology Clinical Trial Product Market Performance
10.17.4 Autolus therapeutics Business Overview
10.17.5 Autolus therapeutics Recent Developments
10.18 Bayer AG
10.18.1 Bayer AG Basic Information
10.18.2 Bayer AG Neurology Clinical Trial Product Overview
10.18.3 Bayer AG Neurology Clinical Trial Product Market Performance
10.18.4 Bayer AG Business Overview
10.18.5 Bayer AG Recent Developments
10.19 Sartorius AG
10.19.1 Sartorius AG Basic Information
10.19.2 Sartorius AG Neurology Clinical Trial Product Overview
10.19.3 Sartorius AG Neurology Clinical Trial Product Market Performance
10.19.4 Sartorius AG Business Overview
10.19.5 Sartorius AG Recent Developments
10.20 Daiichi Sankyo
10.20.1 Daiichi Sankyo Basic Information
10.20.2 Daiichi Sankyo Neurology Clinical Trial Product Overview
10.20.3 Daiichi Sankyo Neurology Clinical Trial Product Market Performance
10.20.4 Daiichi Sankyo Business Overview
10.20.5 Daiichi Sankyo Recent Developments
10.21 Takeda Pharmaceutical Company
10.21.1 Takeda Pharmaceutical Company Basic Information
10.21.2 Takeda Pharmaceutical Company Neurology Clinical Trial Product Overview
10.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Product Market Performance
10.21.4 Takeda Pharmaceutical Company Business Overview
10.21.5 Takeda Pharmaceutical Company Recent Developments
10.22 Sumitomo Chemical Co
10.22.1 Sumitomo Chemical Co Basic Information
10.22.2 Sumitomo Chemical Co Neurology Clinical Trial Product Overview
10.22.3 Sumitomo Chemical Co Neurology Clinical Trial Product Market Performance
10.22.4 Sumitomo Chemical Co Business Overview
10.22.5 Sumitomo Chemical Co Recent Developments
11 NEUROLOGY CLINICAL TRIAL MARKET FORECAST BY REGION
11.1 Global Neurology Clinical Trial Market Size Forecast
11.2 Global Neurology Clinical Trial Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurology Clinical Trial Market Size Forecast by Country
11.2.3 Asia Pacific Neurology Clinical Trial Market Size Forecast by Region
11.2.4 South America Neurology Clinical Trial Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurology Clinical Trial by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Neurology Clinical Trial Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Neurology Clinical Trial by Type (2026-2033)
12.1.2 Global Neurology Clinical Trial Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Neurology Clinical Trial by Type (2026-2033)
12.2 Global Neurology Clinical Trial Market Forecast by Application (2026-2033)
12.2.1 Global Neurology Clinical Trial Sales (K Units) Forecast by Application
12.2.2 Global Neurology Clinical Trial Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurology Clinical Trial
1.2 Key Market Segments
1.2.1 Neurology Clinical Trial Segment by Type
1.2.2 Neurology Clinical Trial Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGY CLINICAL TRIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurology Clinical Trial Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neurology Clinical Trial Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGY CLINICAL TRIAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurology Clinical Trial Product Life Cycle
3.3 Global Neurology Clinical Trial Sales by Manufacturers (2020-2025)
3.4 Global Neurology Clinical Trial Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurology Clinical Trial Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurology Clinical Trial Market Competitive Situation and Trends
3.8.1 Neurology Clinical Trial Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurology Clinical Trial Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGY CLINICAL TRIAL INDUSTRY CHAIN ANALYSIS
4.1 Neurology Clinical Trial Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGY CLINICAL TRIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurology Clinical Trial Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurology Clinical Trial Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGY CLINICAL TRIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurology Clinical Trial Sales Market Share by Type (2020-2025)
6.3 Global Neurology Clinical Trial Market Size Market Share by Type (2020-2025)
6.4 Global Neurology Clinical Trial Price by Type (2020-2025)
7 NEUROLOGY CLINICAL TRIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurology Clinical Trial Market Sales by Application (2020-2025)
7.3 Global Neurology Clinical Trial Market Size (M USD) by Application (2020-2025)
7.4 Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
8 NEUROLOGY CLINICAL TRIAL MARKET SALES BY REGION
8.1 Global Neurology Clinical Trial Sales by Region
8.1.1 Global Neurology Clinical Trial Sales by Region
8.1.2 Global Neurology Clinical Trial Sales Market Share by Region
8.2 Global Neurology Clinical Trial Market Size by Region
8.2.1 Global Neurology Clinical Trial Market Size by Region
8.2.2 Global Neurology Clinical Trial Market Size Market Share by Region
8.3 North America
8.3.1 North America Neurology Clinical Trial Sales by Country
8.3.2 North America Neurology Clinical Trial Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurology Clinical Trial Sales by Country
8.4.2 Europe Neurology Clinical Trial Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurology Clinical Trial Sales by Region
8.5.2 Asia Pacific Neurology Clinical Trial Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurology Clinical Trial Sales by Country
8.6.2 South America Neurology Clinical Trial Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurology Clinical Trial Sales by Region
8.7.2 Middle East and Africa Neurology Clinical Trial Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGY CLINICAL TRIAL MARKET PRODUCTION BY REGION
9.1 Global Production of Neurology Clinical Trial by Region(2020-2025)
9.2 Global Neurology Clinical Trial Revenue Market Share by Region (2020-2025)
9.3 Global Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurology Clinical Trial Production
9.4.1 North America Neurology Clinical Trial Production Growth Rate (2020-2025)
9.4.2 North America Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurology Clinical Trial Production
9.5.1 Europe Neurology Clinical Trial Production Growth Rate (2020-2025)
9.5.2 Europe Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurology Clinical Trial Production (2020-2025)
9.6.1 Japan Neurology Clinical Trial Production Growth Rate (2020-2025)
9.6.2 Japan Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurology Clinical Trial Production (2020-2025)
9.7.1 China Neurology Clinical Trial Production Growth Rate (2020-2025)
9.7.2 China Neurology Clinical Trial Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BrainStorm Cell Therapeutics
10.1.1 BrainStorm Cell Therapeutics Basic Information
10.1.2 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Overview
10.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Market Performance
10.1.4 BrainStorm Cell Therapeutics Business Overview
10.1.5 BrainStorm Cell Therapeutics SWOT Analysis
10.1.6 BrainStorm Cell Therapeutics Recent Developments
10.2 Opexa Therapeutics
10.2.1 Opexa Therapeutics Basic Information
10.2.2 Opexa Therapeutics Neurology Clinical Trial Product Overview
10.2.3 Opexa Therapeutics Neurology Clinical Trial Product Market Performance
10.2.4 Opexa Therapeutics Business Overview
10.2.5 Opexa Therapeutics SWOT Analysis
10.2.6 Opexa Therapeutics Recent Developments
10.3 Caladrius Biosciences
10.3.1 Caladrius Biosciences Basic Information
10.3.2 Caladrius Biosciences Neurology Clinical Trial Product Overview
10.3.3 Caladrius Biosciences Neurology Clinical Trial Product Market Performance
10.3.4 Caladrius Biosciences Business Overview
10.3.5 Caladrius Biosciences SWOT Analysis
10.3.6 Caladrius Biosciences Recent Developments
10.4 U.S. Stem Cell
10.4.1 U.S. Stem Cell Basic Information
10.4.2 U.S. Stem Cell Neurology Clinical Trial Product Overview
10.4.3 U.S. Stem Cell Neurology Clinical Trial Product Market Performance
10.4.4 U.S. Stem Cell Business Overview
10.4.5 U.S. Stem Cell Recent Developments
10.5 Lonza
10.5.1 Lonza Basic Information
10.5.2 Lonza Neurology Clinical Trial Product Overview
10.5.3 Lonza Neurology Clinical Trial Product Market Performance
10.5.4 Lonza Business Overview
10.5.5 Lonza Recent Developments
10.6 Bristol Myers Squibb
10.6.1 Bristol Myers Squibb Basic Information
10.6.2 Bristol Myers Squibb Neurology Clinical Trial Product Overview
10.6.3 Bristol Myers Squibb Neurology Clinical Trial Product Market Performance
10.6.4 Bristol Myers Squibb Business Overview
10.6.5 Bristol Myers Squibb Recent Developments
10.7 Corning Incorporated
10.7.1 Corning Incorporated Basic Information
10.7.2 Corning Incorporated Neurology Clinical Trial Product Overview
10.7.3 Corning Incorporated Neurology Clinical Trial Product Market Performance
10.7.4 Corning Incorporated Business Overview
10.7.5 Corning Incorporated Recent Developments
10.8 Vericel Corporation
10.8.1 Vericel Corporation Basic Information
10.8.2 Vericel Corporation Neurology Clinical Trial Product Overview
10.8.3 Vericel Corporation Neurology Clinical Trial Product Market Performance
10.8.4 Vericel Corporation Business Overview
10.8.5 Vericel Corporation Recent Developments
10.9 Catalent
10.9.1 Catalent Basic Information
10.9.2 Catalent Neurology Clinical Trial Product Overview
10.9.3 Catalent Neurology Clinical Trial Product Market Performance
10.9.4 Catalent Business Overview
10.9.5 Catalent Recent Developments
10.10 Lineage Cell Therapeutics
10.10.1 Lineage Cell Therapeutics Basic Information
10.10.2 Lineage Cell Therapeutics Neurology Clinical Trial Product Overview
10.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Product Market Performance
10.10.4 Lineage Cell Therapeutics Business Overview
10.10.5 Lineage Cell Therapeutics Recent Developments
10.11 Castle Creek Biosciences
10.11.1 Castle Creek Biosciences Basic Information
10.11.2 Castle Creek Biosciences Neurology Clinical Trial Product Overview
10.11.3 Castle Creek Biosciences Neurology Clinical Trial Product Market Performance
10.11.4 Castle Creek Biosciences Business Overview
10.11.5 Castle Creek Biosciences Recent Developments
10.12 Sangamo Therapeutics
10.12.1 Sangamo Therapeutics Basic Information
10.12.2 Sangamo Therapeutics Neurology Clinical Trial Product Overview
10.12.3 Sangamo Therapeutics Neurology Clinical Trial Product Market Performance
10.12.4 Sangamo Therapeutics Business Overview
10.12.5 Sangamo Therapeutics Recent Developments
10.13 Novartis
10.13.1 Novartis Basic Information
10.13.2 Novartis Neurology Clinical Trial Product Overview
10.13.3 Novartis Neurology Clinical Trial Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Holostem Terapie Avanzate S.R.L
10.14.1 Holostem Terapie Avanzate S.R.L Basic Information
10.14.2 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Overview
10.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Market Performance
10.14.4 Holostem Terapie Avanzate S.R.L Business Overview
10.14.5 Holostem Terapie Avanzate S.R.L Recent Developments
10.15 Pharmicell
10.15.1 Pharmicell Basic Information
10.15.2 Pharmicell Neurology Clinical Trial Product Overview
10.15.3 Pharmicell Neurology Clinical Trial Product Market Performance
10.15.4 Pharmicell Business Overview
10.15.5 Pharmicell Recent Developments
10.16 Tego Science
10.16.1 Tego Science Basic Information
10.16.2 Tego Science Neurology Clinical Trial Product Overview
10.16.3 Tego Science Neurology Clinical Trial Product Market Performance
10.16.4 Tego Science Business Overview
10.16.5 Tego Science Recent Developments
10.17 Autolus therapeutics
10.17.1 Autolus therapeutics Basic Information
10.17.2 Autolus therapeutics Neurology Clinical Trial Product Overview
10.17.3 Autolus therapeutics Neurology Clinical Trial Product Market Performance
10.17.4 Autolus therapeutics Business Overview
10.17.5 Autolus therapeutics Recent Developments
10.18 Bayer AG
10.18.1 Bayer AG Basic Information
10.18.2 Bayer AG Neurology Clinical Trial Product Overview
10.18.3 Bayer AG Neurology Clinical Trial Product Market Performance
10.18.4 Bayer AG Business Overview
10.18.5 Bayer AG Recent Developments
10.19 Sartorius AG
10.19.1 Sartorius AG Basic Information
10.19.2 Sartorius AG Neurology Clinical Trial Product Overview
10.19.3 Sartorius AG Neurology Clinical Trial Product Market Performance
10.19.4 Sartorius AG Business Overview
10.19.5 Sartorius AG Recent Developments
10.20 Daiichi Sankyo
10.20.1 Daiichi Sankyo Basic Information
10.20.2 Daiichi Sankyo Neurology Clinical Trial Product Overview
10.20.3 Daiichi Sankyo Neurology Clinical Trial Product Market Performance
10.20.4 Daiichi Sankyo Business Overview
10.20.5 Daiichi Sankyo Recent Developments
10.21 Takeda Pharmaceutical Company
10.21.1 Takeda Pharmaceutical Company Basic Information
10.21.2 Takeda Pharmaceutical Company Neurology Clinical Trial Product Overview
10.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Product Market Performance
10.21.4 Takeda Pharmaceutical Company Business Overview
10.21.5 Takeda Pharmaceutical Company Recent Developments
10.22 Sumitomo Chemical Co
10.22.1 Sumitomo Chemical Co Basic Information
10.22.2 Sumitomo Chemical Co Neurology Clinical Trial Product Overview
10.22.3 Sumitomo Chemical Co Neurology Clinical Trial Product Market Performance
10.22.4 Sumitomo Chemical Co Business Overview
10.22.5 Sumitomo Chemical Co Recent Developments
11 NEUROLOGY CLINICAL TRIAL MARKET FORECAST BY REGION
11.1 Global Neurology Clinical Trial Market Size Forecast
11.2 Global Neurology Clinical Trial Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurology Clinical Trial Market Size Forecast by Country
11.2.3 Asia Pacific Neurology Clinical Trial Market Size Forecast by Region
11.2.4 South America Neurology Clinical Trial Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurology Clinical Trial by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Neurology Clinical Trial Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Neurology Clinical Trial by Type (2026-2033)
12.1.2 Global Neurology Clinical Trial Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Neurology Clinical Trial by Type (2026-2033)
12.2 Global Neurology Clinical Trial Market Forecast by Application (2026-2033)
12.2.1 Global Neurology Clinical Trial Sales (K Units) Forecast by Application
12.2.2 Global Neurology Clinical Trial Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurology Clinical Trial Market Size Comparison by Region (M USD)
Table 5. Global Neurology Clinical Trial Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Neurology Clinical Trial Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Neurology Clinical Trial Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Neurology Clinical Trial Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2024)
Table 10. Global Market Neurology Clinical Trial Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Neurology Clinical Trial Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Neurology Clinical Trial Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Neurology Clinical Trial Sales by Type (K Units)
Table 26. Global Neurology Clinical Trial Market Size by Type (M USD)
Table 27. Global Neurology Clinical Trial Sales (K Units) by Type (2020-2025)
Table 28. Global Neurology Clinical Trial Sales Market Share by Type (2020-2025)
Table 29. Global Neurology Clinical Trial Market Size (M USD) by Type (2020-2025)
Table 30. Global Neurology Clinical Trial Market Size Share by Type (2020-2025)
Table 31. Global Neurology Clinical Trial Price (USD/Unit) by Type (2020-2025)
Table 32. Global Neurology Clinical Trial Sales (K Units) by Application
Table 33. Global Neurology Clinical Trial Market Size by Application
Table 34. Global Neurology Clinical Trial Sales by Application (2020-2025) & (K Units)
Table 35. Global Neurology Clinical Trial Sales Market Share by Application (2020-2025)
Table 36. Global Neurology Clinical Trial Market Size by Application (2020-2025) & (M USD)
Table 37. Global Neurology Clinical Trial Market Share by Application (2020-2025)
Table 38. Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
Table 39. Global Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 40. Global Neurology Clinical Trial Sales Market Share by Region (2020-2025)
Table 41. Global Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 42. Global Neurology Clinical Trial Market Size Market Share by Region (2020-2025)
Table 43. North America Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 44. North America Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 49. South America Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 50. South America Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 53. Global Neurology Clinical Trial Production (K Units) by Region(2020-2025)
Table 54. Global Neurology Clinical Trial Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Neurology Clinical Trial Revenue Market Share by Region (2020-2025)
Table 56. Global Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. BrainStorm Cell Therapeutics Basic Information
Table 62. BrainStorm Cell Therapeutics Neurology Clinical Trial Product Overview
Table 63. BrainStorm Cell Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. BrainStorm Cell Therapeutics Business Overview
Table 65. BrainStorm Cell Therapeutics SWOT Analysis
Table 66. BrainStorm Cell Therapeutics Recent Developments
Table 67. Opexa Therapeutics Basic Information
Table 68. Opexa Therapeutics Neurology Clinical Trial Product Overview
Table 69. Opexa Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Opexa Therapeutics Business Overview
Table 71. Opexa Therapeutics SWOT Analysis
Table 72. Opexa Therapeutics Recent Developments
Table 73. Caladrius Biosciences Basic Information
Table 74. Caladrius Biosciences Neurology Clinical Trial Product Overview
Table 75. Caladrius Biosciences Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Caladrius Biosciences Business Overview
Table 77. Caladrius Biosciences SWOT Analysis
Table 78. Caladrius Biosciences Recent Developments
Table 79. U.S. Stem Cell Basic Information
Table 80. U.S. Stem Cell Neurology Clinical Trial Product Overview
Table 81. U.S. Stem Cell Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. U.S. Stem Cell Business Overview
Table 83. U.S. Stem Cell Recent Developments
Table 84. Lonza Basic Information
Table 85. Lonza Neurology Clinical Trial Product Overview
Table 86. Lonza Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Lonza Business Overview
Table 88. Lonza Recent Developments
Table 89. Bristol Myers Squibb Basic Information
Table 90. Bristol Myers Squibb Neurology Clinical Trial Product Overview
Table 91. Bristol Myers Squibb Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bristol Myers Squibb Business Overview
Table 93. Bristol Myers Squibb Recent Developments
Table 94. Corning Incorporated Basic Information
Table 95. Corning Incorporated Neurology Clinical Trial Product Overview
Table 96. Corning Incorporated Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Corning Incorporated Business Overview
Table 98. Corning Incorporated Recent Developments
Table 99. Vericel Corporation Basic Information
Table 100. Vericel Corporation Neurology Clinical Trial Product Overview
Table 101. Vericel Corporation Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Vericel Corporation Business Overview
Table 103. Vericel Corporation Recent Developments
Table 104. Catalent Basic Information
Table 105. Catalent Neurology Clinical Trial Product Overview
Table 106. Catalent Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Catalent Business Overview
Table 108. Catalent Recent Developments
Table 109. Lineage Cell Therapeutics Basic Information
Table 110. Lineage Cell Therapeutics Neurology Clinical Trial Product Overview
Table 111. Lineage Cell Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lineage Cell Therapeutics Business Overview
Table 113. Lineage Cell Therapeutics Recent Developments
Table 114. Castle Creek Biosciences Basic Information
Table 115. Castle Creek Biosciences Neurology Clinical Trial Product Overview
Table 116. Castle Creek Biosciences Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Castle Creek Biosciences Business Overview
Table 118. Castle Creek Biosciences Recent Developments
Table 119. Sangamo Therapeutics Basic Information
Table 120. Sangamo Therapeutics Neurology Clinical Trial Product Overview
Table 121. Sangamo Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Neurology Clinical Trial Product Overview
Table 126. Novartis Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Holostem Terapie Avanzate S.R.L Basic Information
Table 130. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Overview
Table 131. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Holostem Terapie Avanzate S.R.L Business Overview
Table 133. Holostem Terapie Avanzate S.R.L Recent Developments
Table 134. Pharmicell Basic Information
Table 135. Pharmicell Neurology Clinical Trial Product Overview
Table 136. Pharmicell Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Pharmicell Business Overview
Table 138. Pharmicell Recent Developments
Table 139. Tego Science Basic Information
Table 140. Tego Science Neurology Clinical Trial Product Overview
Table 141. Tego Science Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Tego Science Business Overview
Table 143. Tego Science Recent Developments
Table 144. Autolus therapeutics Basic Information
Table 145. Autolus therapeutics Neurology Clinical Trial Product Overview
Table 146. Autolus therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Autolus therapeutics Business Overview
Table 148. Autolus therapeutics Recent Developments
Table 149. Bayer AG Basic Information
Table 150. Bayer AG Neurology Clinical Trial Product Overview
Table 151. Bayer AG Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Bayer AG Business Overview
Table 153. Bayer AG Recent Developments
Table 154. Sartorius AG Basic Information
Table 155. Sartorius AG Neurology Clinical Trial Product Overview
Table 156. Sartorius AG Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Sartorius AG Business Overview
Table 158. Sartorius AG Recent Developments
Table 159. Daiichi Sankyo Basic Information
Table 160. Daiichi Sankyo Neurology Clinical Trial Product Overview
Table 161. Daiichi Sankyo Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Daiichi Sankyo Business Overview
Table 163. Daiichi Sankyo Recent Developments
Table 164. Takeda Pharmaceutical Company Basic Information
Table 165. Takeda Pharmaceutical Company Neurology Clinical Trial Product Overview
Table 166. Takeda Pharmaceutical Company Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Takeda Pharmaceutical Company Business Overview
Table 168. Takeda Pharmaceutical Company Recent Developments
Table 169. Sumitomo Chemical Co Basic Information
Table 170. Sumitomo Chemical Co Neurology Clinical Trial Product Overview
Table 171. Sumitomo Chemical Co Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Sumitomo Chemical Co Business Overview
Table 173. Sumitomo Chemical Co Recent Developments
Table 174. Global Neurology Clinical Trial Sales Forecast by Region (2026-2033) & (K Units)
Table 175. Global Neurology Clinical Trial Market Size Forecast by Region (2026-2033) & (M USD)
Table 176. North America Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 177. North America Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 178. Europe Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 179. Europe Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 180. Asia Pacific Neurology Clinical Trial Sales Forecast by Region (2026-2033) & (K Units)
Table 181. Asia Pacific Neurology Clinical Trial Market Size Forecast by Region (2026-2033) & (M USD)
Table 182. South America Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 183. South America Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 184. Middle East and Africa Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (Units)
Table 185. Middle East and Africa Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 186. Global Neurology Clinical Trial Sales Forecast by Type (2026-2033) & (K Units)
Table 187. Global Neurology Clinical Trial Market Size Forecast by Type (2026-2033) & (M USD)
Table 188. Global Neurology Clinical Trial Price Forecast by Type (2026-2033) & (USD/Unit)
Table 189. Global Neurology Clinical Trial Sales (K Units) Forecast by Application (2026-2033)
Table 190. Global Neurology Clinical Trial Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurology Clinical Trial Market Size Comparison by Region (M USD)
Table 5. Global Neurology Clinical Trial Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Neurology Clinical Trial Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Neurology Clinical Trial Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Neurology Clinical Trial Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2024)
Table 10. Global Market Neurology Clinical Trial Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Neurology Clinical Trial Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Neurology Clinical Trial Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Neurology Clinical Trial Sales by Type (K Units)
Table 26. Global Neurology Clinical Trial Market Size by Type (M USD)
Table 27. Global Neurology Clinical Trial Sales (K Units) by Type (2020-2025)
Table 28. Global Neurology Clinical Trial Sales Market Share by Type (2020-2025)
Table 29. Global Neurology Clinical Trial Market Size (M USD) by Type (2020-2025)
Table 30. Global Neurology Clinical Trial Market Size Share by Type (2020-2025)
Table 31. Global Neurology Clinical Trial Price (USD/Unit) by Type (2020-2025)
Table 32. Global Neurology Clinical Trial Sales (K Units) by Application
Table 33. Global Neurology Clinical Trial Market Size by Application
Table 34. Global Neurology Clinical Trial Sales by Application (2020-2025) & (K Units)
Table 35. Global Neurology Clinical Trial Sales Market Share by Application (2020-2025)
Table 36. Global Neurology Clinical Trial Market Size by Application (2020-2025) & (M USD)
Table 37. Global Neurology Clinical Trial Market Share by Application (2020-2025)
Table 38. Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
Table 39. Global Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 40. Global Neurology Clinical Trial Sales Market Share by Region (2020-2025)
Table 41. Global Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 42. Global Neurology Clinical Trial Market Size Market Share by Region (2020-2025)
Table 43. North America Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 44. North America Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 49. South America Neurology Clinical Trial Sales by Country (2020-2025) & (K Units)
Table 50. South America Neurology Clinical Trial Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Neurology Clinical Trial Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Neurology Clinical Trial Market Size by Region (2020-2025) & (M USD)
Table 53. Global Neurology Clinical Trial Production (K Units) by Region(2020-2025)
Table 54. Global Neurology Clinical Trial Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Neurology Clinical Trial Revenue Market Share by Region (2020-2025)
Table 56. Global Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Neurology Clinical Trial Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. BrainStorm Cell Therapeutics Basic Information
Table 62. BrainStorm Cell Therapeutics Neurology Clinical Trial Product Overview
Table 63. BrainStorm Cell Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. BrainStorm Cell Therapeutics Business Overview
Table 65. BrainStorm Cell Therapeutics SWOT Analysis
Table 66. BrainStorm Cell Therapeutics Recent Developments
Table 67. Opexa Therapeutics Basic Information
Table 68. Opexa Therapeutics Neurology Clinical Trial Product Overview
Table 69. Opexa Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Opexa Therapeutics Business Overview
Table 71. Opexa Therapeutics SWOT Analysis
Table 72. Opexa Therapeutics Recent Developments
Table 73. Caladrius Biosciences Basic Information
Table 74. Caladrius Biosciences Neurology Clinical Trial Product Overview
Table 75. Caladrius Biosciences Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Caladrius Biosciences Business Overview
Table 77. Caladrius Biosciences SWOT Analysis
Table 78. Caladrius Biosciences Recent Developments
Table 79. U.S. Stem Cell Basic Information
Table 80. U.S. Stem Cell Neurology Clinical Trial Product Overview
Table 81. U.S. Stem Cell Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. U.S. Stem Cell Business Overview
Table 83. U.S. Stem Cell Recent Developments
Table 84. Lonza Basic Information
Table 85. Lonza Neurology Clinical Trial Product Overview
Table 86. Lonza Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Lonza Business Overview
Table 88. Lonza Recent Developments
Table 89. Bristol Myers Squibb Basic Information
Table 90. Bristol Myers Squibb Neurology Clinical Trial Product Overview
Table 91. Bristol Myers Squibb Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bristol Myers Squibb Business Overview
Table 93. Bristol Myers Squibb Recent Developments
Table 94. Corning Incorporated Basic Information
Table 95. Corning Incorporated Neurology Clinical Trial Product Overview
Table 96. Corning Incorporated Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Corning Incorporated Business Overview
Table 98. Corning Incorporated Recent Developments
Table 99. Vericel Corporation Basic Information
Table 100. Vericel Corporation Neurology Clinical Trial Product Overview
Table 101. Vericel Corporation Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Vericel Corporation Business Overview
Table 103. Vericel Corporation Recent Developments
Table 104. Catalent Basic Information
Table 105. Catalent Neurology Clinical Trial Product Overview
Table 106. Catalent Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Catalent Business Overview
Table 108. Catalent Recent Developments
Table 109. Lineage Cell Therapeutics Basic Information
Table 110. Lineage Cell Therapeutics Neurology Clinical Trial Product Overview
Table 111. Lineage Cell Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lineage Cell Therapeutics Business Overview
Table 113. Lineage Cell Therapeutics Recent Developments
Table 114. Castle Creek Biosciences Basic Information
Table 115. Castle Creek Biosciences Neurology Clinical Trial Product Overview
Table 116. Castle Creek Biosciences Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Castle Creek Biosciences Business Overview
Table 118. Castle Creek Biosciences Recent Developments
Table 119. Sangamo Therapeutics Basic Information
Table 120. Sangamo Therapeutics Neurology Clinical Trial Product Overview
Table 121. Sangamo Therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Neurology Clinical Trial Product Overview
Table 126. Novartis Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Holostem Terapie Avanzate S.R.L Basic Information
Table 130. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Overview
Table 131. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Holostem Terapie Avanzate S.R.L Business Overview
Table 133. Holostem Terapie Avanzate S.R.L Recent Developments
Table 134. Pharmicell Basic Information
Table 135. Pharmicell Neurology Clinical Trial Product Overview
Table 136. Pharmicell Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Pharmicell Business Overview
Table 138. Pharmicell Recent Developments
Table 139. Tego Science Basic Information
Table 140. Tego Science Neurology Clinical Trial Product Overview
Table 141. Tego Science Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Tego Science Business Overview
Table 143. Tego Science Recent Developments
Table 144. Autolus therapeutics Basic Information
Table 145. Autolus therapeutics Neurology Clinical Trial Product Overview
Table 146. Autolus therapeutics Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Autolus therapeutics Business Overview
Table 148. Autolus therapeutics Recent Developments
Table 149. Bayer AG Basic Information
Table 150. Bayer AG Neurology Clinical Trial Product Overview
Table 151. Bayer AG Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Bayer AG Business Overview
Table 153. Bayer AG Recent Developments
Table 154. Sartorius AG Basic Information
Table 155. Sartorius AG Neurology Clinical Trial Product Overview
Table 156. Sartorius AG Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Sartorius AG Business Overview
Table 158. Sartorius AG Recent Developments
Table 159. Daiichi Sankyo Basic Information
Table 160. Daiichi Sankyo Neurology Clinical Trial Product Overview
Table 161. Daiichi Sankyo Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Daiichi Sankyo Business Overview
Table 163. Daiichi Sankyo Recent Developments
Table 164. Takeda Pharmaceutical Company Basic Information
Table 165. Takeda Pharmaceutical Company Neurology Clinical Trial Product Overview
Table 166. Takeda Pharmaceutical Company Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Takeda Pharmaceutical Company Business Overview
Table 168. Takeda Pharmaceutical Company Recent Developments
Table 169. Sumitomo Chemical Co Basic Information
Table 170. Sumitomo Chemical Co Neurology Clinical Trial Product Overview
Table 171. Sumitomo Chemical Co Neurology Clinical Trial Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Sumitomo Chemical Co Business Overview
Table 173. Sumitomo Chemical Co Recent Developments
Table 174. Global Neurology Clinical Trial Sales Forecast by Region (2026-2033) & (K Units)
Table 175. Global Neurology Clinical Trial Market Size Forecast by Region (2026-2033) & (M USD)
Table 176. North America Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 177. North America Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 178. Europe Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 179. Europe Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 180. Asia Pacific Neurology Clinical Trial Sales Forecast by Region (2026-2033) & (K Units)
Table 181. Asia Pacific Neurology Clinical Trial Market Size Forecast by Region (2026-2033) & (M USD)
Table 182. South America Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (K Units)
Table 183. South America Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 184. Middle East and Africa Neurology Clinical Trial Sales Forecast by Country (2026-2033) & (Units)
Table 185. Middle East and Africa Neurology Clinical Trial Market Size Forecast by Country (2026-2033) & (M USD)
Table 186. Global Neurology Clinical Trial Sales Forecast by Type (2026-2033) & (K Units)
Table 187. Global Neurology Clinical Trial Market Size Forecast by Type (2026-2033) & (M USD)
Table 188. Global Neurology Clinical Trial Price Forecast by Type (2026-2033) & (USD/Unit)
Table 189. Global Neurology Clinical Trial Sales (K Units) Forecast by Application (2026-2033)
Table 190. Global Neurology Clinical Trial Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neurology Clinical Trial
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurology Clinical Trial Market Size (M USD), 2024-2033
Figure 5. Global Neurology Clinical Trial Market Size (M USD) (2020-2033)
Figure 6. Global Neurology Clinical Trial Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurology Clinical Trial Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurology Clinical Trial Product Life Cycle
Figure 13. Neurology Clinical Trial Sales Share by Manufacturers in 2024
Figure 14. Global Neurology Clinical Trial Revenue Share by Manufacturers in 2024
Figure 15. Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neurology Clinical Trial Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurology Clinical Trial Revenue in 2024
Figure 18. Industry Chain Map of Neurology Clinical Trial
Figure 19. Global Neurology Clinical Trial Market PEST Analysis
Figure 20. Global Neurology Clinical Trial Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurology Clinical Trial Market Share by Type
Figure 27. Sales Market Share of Neurology Clinical Trial by Type (2020-2025)
Figure 28. Sales Market Share of Neurology Clinical Trial by Type in 2024
Figure 29. Market Size Share of Neurology Clinical Trial by Type (2020-2025)
Figure 30. Market Size Share of Neurology Clinical Trial by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurology Clinical Trial Market Share by Application
Figure 33. Global Neurology Clinical Trial Sales Market Share by Application (2020-2025)
Figure 34. Global Neurology Clinical Trial Sales Market Share by Application in 2024
Figure 35. Global Neurology Clinical Trial Market Share by Application (2020-2025)
Figure 36. Global Neurology Clinical Trial Market Share by Application in 2024
Figure 37. Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurology Clinical Trial Sales Market Share by Region (2020-2025)
Figure 39. Global Neurology Clinical Trial Market Size Market Share by Region (2020-2025)
Figure 40. North America Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 43. North America Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 45. U.S. Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurology Clinical Trial Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neurology Clinical Trial Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurology Clinical Trial Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurology Clinical Trial Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 53. Europe Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 55. Germany Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neurology Clinical Trial Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurology Clinical Trial Market Size Market Share by Region in 2024
Figure 68. China Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 79. South America Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 80. South America Neurology Clinical Trial Market Size and Growth Rate (M USD)
Figure 81. South America Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 82. Brazil Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neurology Clinical Trial Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurology Clinical Trial Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurology Clinical Trial Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurology Clinical Trial Production Market Share by Region (2020-2025)
Figure 103. North America Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neurology Clinical Trial Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Neurology Clinical Trial Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Neurology Clinical Trial Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Neurology Clinical Trial Market Share Forecast by Type (2026-2033)
Figure 111. Global Neurology Clinical Trial Sales Forecast by Application (2026-2033)
Figure 112. Global Neurology Clinical Trial Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Neurology Clinical Trial
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurology Clinical Trial Market Size (M USD), 2024-2033
Figure 5. Global Neurology Clinical Trial Market Size (M USD) (2020-2033)
Figure 6. Global Neurology Clinical Trial Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurology Clinical Trial Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurology Clinical Trial Product Life Cycle
Figure 13. Neurology Clinical Trial Sales Share by Manufacturers in 2024
Figure 14. Global Neurology Clinical Trial Revenue Share by Manufacturers in 2024
Figure 15. Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neurology Clinical Trial Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurology Clinical Trial Revenue in 2024
Figure 18. Industry Chain Map of Neurology Clinical Trial
Figure 19. Global Neurology Clinical Trial Market PEST Analysis
Figure 20. Global Neurology Clinical Trial Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurology Clinical Trial Market Share by Type
Figure 27. Sales Market Share of Neurology Clinical Trial by Type (2020-2025)
Figure 28. Sales Market Share of Neurology Clinical Trial by Type in 2024
Figure 29. Market Size Share of Neurology Clinical Trial by Type (2020-2025)
Figure 30. Market Size Share of Neurology Clinical Trial by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurology Clinical Trial Market Share by Application
Figure 33. Global Neurology Clinical Trial Sales Market Share by Application (2020-2025)
Figure 34. Global Neurology Clinical Trial Sales Market Share by Application in 2024
Figure 35. Global Neurology Clinical Trial Market Share by Application (2020-2025)
Figure 36. Global Neurology Clinical Trial Market Share by Application in 2024
Figure 37. Global Neurology Clinical Trial Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurology Clinical Trial Sales Market Share by Region (2020-2025)
Figure 39. Global Neurology Clinical Trial Market Size Market Share by Region (2020-2025)
Figure 40. North America Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 43. North America Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 45. U.S. Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurology Clinical Trial Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neurology Clinical Trial Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurology Clinical Trial Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurology Clinical Trial Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 53. Europe Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 55. Germany Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neurology Clinical Trial Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurology Clinical Trial Market Size Market Share by Region in 2024
Figure 68. China Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 79. South America Neurology Clinical Trial Sales Market Share by Country in 2024
Figure 80. South America Neurology Clinical Trial Market Size and Growth Rate (M USD)
Figure 81. South America Neurology Clinical Trial Market Size Market Share by Country in 2024
Figure 82. Brazil Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurology Clinical Trial Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neurology Clinical Trial Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurology Clinical Trial Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurology Clinical Trial Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurology Clinical Trial Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neurology Clinical Trial Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurology Clinical Trial Production Market Share by Region (2020-2025)
Figure 103. North America Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neurology Clinical Trial Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neurology Clinical Trial Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Neurology Clinical Trial Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Neurology Clinical Trial Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Neurology Clinical Trial Market Share Forecast by Type (2026-2033)
Figure 111. Global Neurology Clinical Trial Sales Forecast by Application (2026-2033)
Figure 112. Global Neurology Clinical Trial Market Share Forecast by Application (2026-2033)
